98%
921
2 minutes
20
Background: Atopic dermatitis has the highest burden of all skin diseases globally. While numerous systematic reviews and meta-analyses have attempted to estimate the burden of atopic dermatitis at country, regional, and global levels, the variability in research methodology often leads to the exclusion of significant portions of data or the aggregation of data representing disparate factors. As a result, improving the understanding of the burden of atopic dermatitis requires a thorough review of the methodologies currently in use.
Objective: This scoping review aims to identify and map the research methodology used in population-based epidemiological studies of atopic dermatitis in terms of the case definitions used, the severity assessment method, measures of frequency and key socio-demographic factors.
Methods: A systematic literature search was conducted covering an 18-month period from 1st January 2023 to 31st July 2024. Original, population-based studies were included if they reported the prevalence and/or incidence of atopic dermatitis. Abstract screening and data extraction was done in duplicate and blinded. Descriptive analyses stratified by geographic region and age group are presented in tabular and graphical form.
Results: A total of 111 studies were included across 48 countries. Data on atopic dermatitis prevalence used various diagnostic criteria, with studies defining cases by a physician diagnosis (69%), validated questionnaires (13%), and other methods (19%) with considerable heterogeneity between geographic regions. Nineteen studies (17%) reported the severity distribution. Geographical regions with the fewest studies on atopic dermatitis were the South-East Asian (4%) and African (3%) regions.
Conclusion: Recent population-based epidemiological studies on atopic dermatitis are highly heterogeneous, limiting meaningful comparisons across studies. Future research should aim to address this variability and fill key geographical gaps in the global burden data.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/bjd/ljaf238 | DOI Listing |
Int Immunopharmacol
September 2025
Clinical Research Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi 214023, China. Electronic address:
Allergic diseases, characterized by complex pathological mechanisms involving immune dysregulation and chronic inflammation, impose a substantial burden on global health. The Hippo signaling pathway, a highly conserved regulator of cell proliferation, apoptosis, immune homeostasis, and tissue repair, has recently emerged as a pivotal player in allergic disease pathogenesis. This review synthesizes current knowledge on the core components and physiological functions of the Hippo pathway, elucidates its mechanistic roles in major allergic disorders-including allergic asthma, allergic rhinitis, atopic dermatitis, and food allergies-and evaluates the therapeutic potential of targeting this pathway.
View Article and Find Full Text PDFJ Invest Dermatol
September 2025
Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Allergol Int
September 2025
Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan; Faculty of International Liberal Arts, Juntendo University, Tokyo, Japan. Electronic address:
The epidermal immune microenvironment is a multifaceted system in which the interplay between the skin microbiome and antimicrobial peptides plays a pivotal role in sustaining skin homeostasis and preventing dysbiosis. Disruption of these interactions can lead to inflammatory skin conditions such as atopic dermatitis. This review aims to explore the complex mechanisms by which antimicrobial peptides and the skin microbiome communicate within the epidermal immune microenvironment, emphasizing causal dynamics and the dual role of antimicrobial peptides.
View Article and Find Full Text PDFLancet Respir Med
September 2025
Department for Paediatric Pneumology, Allergology, and Neonatology and German Center for Lung Research, Biomedical Research in Endstage and Obstructive Lung Disease, Hannover Medical School, 30625 Hannover, Germany. Electronic address:
Biochem Biophys Res Commun
September 2025
Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan; A∗STAR Skin Research Labs (A∗SRL), Skin Research Institute of Singapore (SRIS), Singapore Immunology Network (SIgN), Agency for Science, Technology, and Research (A∗STAR), 8A Biomedical Grove, IMMUNOS Buildi
Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by eczematous lesions, intense itching, and compromised skin barrier function. Despite the advent of new therapeutics, many individuals still face insufficient disease control, high costs, and relapse. Protease-activated receptor 2 (PAR-2), overexpressed in AD lesions, plays a central role in promoting inflammation, itch, and alterations in epidermal homeostasis.
View Article and Find Full Text PDF